Lilly China Research and Development Center

Eli Lilly and Company
Eli Lilly and Company is headquartered in Indianapolis, USA, and employs over 35,000 people globally. For more than 135 years, Lilly has been dedicated to the mission of meeting the health care needs of people around the world. We address these needs primarily by developing innovative medicines through drug discovery research and development.

Lilly China Research & Development Center in Shanghai Lilly has an established diabetes franchise with the strategy to commercialize first-in-class and best-in-class treatments to address unmet medical needs. As an integral part of our R&D investment, Lilly has recently established the Lilly China Research & Development Center (LCRDC) in Shanghai, China. The new center will focus primarily on discovering new medicines to treat diabetes with the aim of improving the health of diabetes patients in China and globally.

公司地址：上海市浦张江高科技园区伽利略路338号8号楼邮编： 201203